FC
Farallon Capital Management, L.L.C. cut its TNGX stake below 5%
Farallon Capital Management, L.L.C. reported owning 4.9% of Tango Therapeutics, Inc. (TNGX) (8,543,875 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G